Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab With Platinum-doublet Chemotherapy and Adaptive Radiotherapy in Stage III NSCLC
NCT07138755Phase 2Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2025
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in non-small cell lung cancer (NSCLC), sponsored by Third Xiangya Hospital, Central South University. Started Aug 2025; status: recruiting.
02
Drugs
sintilimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07138755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138755.